Detalles de la búsqueda
1.
Does rehabilitation pose a risk to patients suffering from haemato-oncological diseases? Results of a monocentric, retrospective analysis in Germany.
Eur J Cancer Care (Engl)
; 29(2): e13201, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808982
2.
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Eur J Haematol
; 99(1): 42-50, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370401
3.
Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Mol Carcinog
; 55(12): 1927-1939, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023728
4.
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
BMC Cancer
; 16: 290, 2016 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114074
5.
Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
BMC Cancer
; 15: 68, 2015 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886144
6.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 42(1): 26-37, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37753960
7.
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial.
Cancers (Basel)
; 15(18)2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760637
8.
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.
Blood Adv
; 7(4): 469-481, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35917568
9.
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Leukemia
; 37(7): 1521-1529, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316728
10.
Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.
Onkologie
; 35(9): 487-92, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23007145
11.
Organ siderosis and hemophagocytosis during acute graft-versus-host disease.
Haematologica
; 101(8): e344-6, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27198715
12.
MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease.
Gut
; 59(8): 1079-87, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20639251
13.
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias.
Biology (Basel)
; 10(7)2021 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34356484
14.
CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.
Front Immunol
; 12: 736137, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659226
15.
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
Blood Cancer J
; 11(3): 53, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677466
16.
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Leukemia
; 35(4): 1134-1144, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32694619
17.
The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius.
Transpl Immunol
; 18(2): 85-7, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18005849
18.
A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.
Int J Hematol
; 85(4): 326-32, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17483077
19.
The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
Exp Hematol
; 34(6): 753-9, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16728280
20.
Error management of emergency transfusions: a surveillance system to detect safety risks in day to day practice.
Transfus Apher Sci
; 35(2): 125-30, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17045844